Inherited Factor II deficiency
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Hypoprothrombinemia (OR 1.676, 95% CI 1.275-2.203) and prothrombin time (PT) prolongation (OR 2.050, 95% CI 1.398-3.005) were significantly associated with NMTT-cephalosporins, whereas bleeding was not (OR 1.359, 95% CI 0.920-2.009).
|
31623191 |
2019 |
Inherited Factor II deficiency
|
0.800 |
GermlineCausalMutation
|
disease |
ORPHANET |
A novel congenital dysprothrombinemia leading to defective prothrombin maturation.
|
25242243 |
2014 |
Inherited Factor II deficiency
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Prophylactic administration of prothrombin complex concentrates for congenital prothrombin deficiency with a novel frameshift mutation, prothrombin saitama.
|
23152198 |
2013 |
Inherited Factor II deficiency
|
0.800 |
GermlineCausalMutation
|
disease |
ORPHANET |
Congenital prothrombin deficiency: an update.
|
23852823 |
2013 |
Inherited Factor II deficiency
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Thrombophilia: 2009 update.
|
19289024 |
2009 |
Inherited Factor II deficiency
|
0.800 |
GeneticVariation
|
disease |
LHGDN |
True congenital prothrombin deficiency due to a 'new' mutation in the pre-propeptide (ARG-39 GLN).
|
18852482 |
2008 |
Inherited Factor II deficiency
|
0.800 |
Biomarker
|
disease |
BEFREE |
Prothrombin (factor II) deficiency is a rare autosomal recessive coagulation disorder that occurs in approximately 1 in 1-2 million people.
|
19141155 |
2008 |
Inherited Factor II deficiency
|
0.800 |
GeneticVariation
|
disease |
LHGDN |
Severe prothrombin deficiency caused by prothrombin-Edmonton (R-4Q) combined with a previously undetected deletion.
|
17002658 |
2006 |
Inherited Factor II deficiency
|
0.800 |
GeneticVariation
|
disease |
LHGDN |
Molecular genetics of hereditary prothrombin deficiency in Indian patients: identification of a novel Ala362 --> Thr (Prothrombin Vellore 1) mutation.
|
15892853 |
2005 |
Inherited Factor II deficiency
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Prothrombin Shanghai: hypoprothrombinaemia caused by substitution of Gla29 by Gly.
|
14962227 |
2004 |
Inherited Factor II deficiency
|
0.800 |
Biomarker
|
disease |
BEFREE |
The primary effect of this defect appears to be destabilization of the circulating prothrombin, creating a moderate hypoprothrombinemia.
|
14629473 |
2003 |
Inherited Factor II deficiency
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Geographic distribution of the 20210 G to A prothrombin variant.
|
9569177 |
1998 |
Inherited Factor II deficiency
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
Cases with a parallel decrease in prothrombin activity and antigen should not be considered as examples of hypoprothrombinemia.
|
9863703 |
1998 |
Inherited Factor II deficiency
|
0.800 |
Biomarker
|
disease |
BEFREE |
Automated fluorescence-based DNA sequence analysis of amplified genomic DNA was used to define prothrombin gene regions from a patient with severe functional hypoprothrombinemia and little detectable prothrombin antigen.
|
9351523 |
1997 |
Inherited Factor II deficiency
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The abnormal prothrombin gene of an Italian patient with a severe bleeding tendency and hypoprothrombinemia was selected for study and compared with the prothrombin genes of healthy controls.
|
9134629 |
1997 |
Inherited Factor II deficiency
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Prothrombin Frankfurt: a dysfunctional prothrombin characterized by substitution of Glu-466 by Ala.
|
7792730 |
1995 |
Inherited Factor II deficiency
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
A patient with a severe bleeding tendency and hypoprothrombinemia (Factor II activity 2%, Factor II antigen 5%) was screened for the presence of alterations in his prothrombin gene.
|
7740448 |
1994 |
Inherited Factor II deficiency
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Prothrombin Padua I: incomplete activation due to an amino acid substitution at a factor Xa cleavage site.
|
7865694 |
1994 |
Inherited Factor II deficiency
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Prothrombin Himi: a compound heterozygote for two dysfunctional prothrombin molecules (Met-337-->Thr and Arg-388-->His).
|
1421398 |
1992 |
Inherited Factor II deficiency
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Detection of a single base substitution of the gene for prothrombin Tokushima. The application of PCR-SSCP for the genetic and molecular analysis of dysprothrombinemia.
|
1349838 |
1992 |
Inherited Factor II deficiency
|
0.800 |
Biomarker
|
disease |
BEFREE |
Molecular and genetic analysis of a compound heterozygote for dysprothrombinemia of prothrombin Tokushima and hypoprothrombinemia.
|
1334372 |
1992 |
Inherited Factor II deficiency
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Prothrombin Salakta: substitution of glutamic acid-466 by alanine reduces the fibrinogen clotting activity and the esterase activity.
|
1354985 |
1992 |
Inherited Factor II deficiency
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Substitution of valine for glycine-558 in the congenital dysthrombin thrombin Quick II alters primary substrate specificity.
|
2719946 |
1989 |
Inherited Factor II deficiency
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Identification of the primary structural defect in the dysthrombin thrombin Quick I: substitution of cysteine for arginine-382.
|
3242619 |
1988 |
Inherited Factor II deficiency
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
The prothrombin sample used was from a heterozygote but contained exclusively a defective prothrombin molecule, since the patient was heterozygous for both dysprothrombinemia and hypoprothrombinemia.
|
3567158 |
1987 |